Guardant Health, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Roberto Mignone, a Director of Guardant Health, Inc., reported multiple transactions in common stock on September 21, 2026.
NASDAQ
Medina Manuel Hidalgo, a Director of Guardant Health, Inc., reported multiple transactions in common stock on September 17, 2026.
NASDAQ
Form 4: Guardant Health CTO Sells Shares
Darya Chudova, Chief Technology Officer of Guardant Health, Inc., sold 7,738 shares of common stock on September 15, 2026 for $178.00 per share.
NASDAQ
Steve E. Krognes, a Director of Guardant Health, Inc., sold 6,674 shares of common stock on September 16, 2026.
NASDAQ
Alex M Azar Ii, a Director of Guardant Health, Inc., sold 826 shares of common stock on September 16, 2026 for $175.00 per share.
NASDAQ
Musa Tariq, a Director of Guardant Health, Inc., sold 116 shares of common stock on September 15, 2026 for $175.00 per share.
NASDAQ
Alex M Azar Ii, a Director of Guardant Health, Inc., reported multiple transactions in common stock on September 12, 2026.
NASDAQ
Kumud Kalia, Chief Information Officer of Guardant Health, Inc., sold 4,000 shares of common stock on September 11, 2026 for $158.05 per share.
NASDAQ
Helmy Eltoukhy, Co-Chief Executive Officer and a Director of Guardant Health, Inc., reported multiple transactions in common stock on August 26, 2026.
NASDAQ
Form 4: Guardant Health CEO Sells Shares
Amirali Talasaz, Co-Chief Executive Officer and a Director of Guardant Health, Inc., sold 37,500 shares of common stock on August 21, 2026.
NASDAQ
Roberto Mignone, a Director of Guardant Health, Inc., reported multiple transactions in common stock on August 21, 2026.
NASDAQ
Medina Manuel Hidalgo, a Director of Guardant Health, Inc., reported multiple transactions in common stock on August 17, 2026.
NASDAQ
Musa Tariq, a Director of Guardant Health, Inc., sold 116 shares of common stock on August 15, 2026 for $156.45 per share.
NASDAQ
Terilyn J. Monroe, Chief People Officer of Guardant Health, Inc., sold 46,300 shares of common stock on August 12, 2026.
NASDAQ
Helmy Eltoukhy, Co-Chief Executive Officer and a Director of Guardant Health, Inc., reported multiple transactions in common stock on August 11, 2026.
NASDAQ
Amirali Talasaz, Co-Chief Executive Officer and a Director of Guardant Health, Inc., reported multiple transactions in common stock on August 10, 2026.
NASDAQ
John G. Saia, Chief Legal Officer of Guardant Health, Inc., reported a transaction in 800 shares of common stock on August 10, 2026.
NASDAQ
Chris Freeman, Chief Commercial Officer of Guardant Health, Inc., sold 63,605 shares of common stock on August 10, 2026.
NASDAQ
Medina Manuel Hidalgo, a Director of Guardant Health, Inc., sold 1,700 shares of common stock on August 5, 2026.
NASDAQ
Ian T Clark, a Director of Guardant Health, Inc., sold 14,180 shares of common stock on August 4, 2026.
NASDAQ
Roberto Mignone, a Director of Guardant Health, Inc., reported multiple transactions in common stock on July 21, 2026.
NASDAQ
Medina Manuel Hidalgo, a Director of Guardant Health, Inc., reported multiple transactions in common stock on July 17, 2026.
NASDAQ
Musa Tariq, a Director of Guardant Health, Inc., sold 116 shares of common stock on July 15, 2026 for $163.29 per share.
NASDAQ
Guardant Health's Chief Legal Officer, John G. Saia, reported transactions involving the acquisition of common stock and restricted stock units.
NASDAQ
Terilyn J. Monroe, Chief People Officer at Guardant Health, Inc., reported transactions involving restricted stock units and common stock.
NASDAQ
Guardant Health, Inc. executive Kumud Kalia reported transactions involving the acquisition of common stock and restricted stock units.
NASDAQ
Guardant Health's Chief Commercial Officer, Chris Freeman, reported transactions involving the acquisition of common stock and restricted stock units.
NASDAQ
Darya Chudova, Chief Technology Officer at Guardant Health, Inc., reported transactions involving restricted stock units and common stock.
NASDAQ
Guardant Health's Chief Financial Officer, Michael Brian Bell, acquired shares through the vesting of restricted stock units and retained shares for tax withholding.
NASDAQ
Guardant Health Co-CEO Helmy Eltoukhy reported transactions involving common stock and restricted stock units on June 30 and July 1, 2026.